Congenital rubella syndrome historical perspective

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: :Kalsang Dolma, M.B.B.S.[2]

Congenital infections Main Page

Congenital Rubella Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital Rubella Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

CDC Case Definitions

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Congenital rubella syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital rubella syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital rubella syndrome historical perspective

CDC on Congenital rubella syndrome historical perspective

Congenital rubella syndrome historical perspective in the news

Blogs on Congenital rubella syndrome historical perspective

Directions to Hospitals Treating Congenital rubella syndrome

Risk calculators and risk factors for Congenital rubella syndrome historical perspective

Overview

Historical Perspective

The link between congenital cataracts and maternal rubella infection was first made in 1941 by Australian ophthalmologist, Norman Gregg, who had noticed an unusual number of infants with cataracts following a rubella epidemic in 1940. In the absence of vaccination, rubella is an endemic disease with epidemics every 6 to 9 years. If rubella infections occurred among nonimmune pregnant women, CRS cases can occur. During the 1962–1965 global rubella pandemic, an estimated 12.5 million rubella cases occurred in the United States, resulting in 2,000 cases of encephalitis, 11,250 therapeutic or spontaneous abortions, 2,100 neonatal deaths, and 20,000 infants born with CRS.

In 1969, live attenuated rubella vaccines were licensed in the United States. The goal of the rubella vaccination program was and continues to be to prevent congenital rubella infections, including CRS. Following vaccine licensure, the number of reported cases of CRS in the United States declined dramatically to <1 case per year or 4 cases total during 2005–2011 (CDC, unpublished data). In 28 (85%) of the 33 cases occurring during 1998–2011, the mother was born outside the United States. Of the 33 CRS cases occurring during this time, 16 (48%) were known importations (CDC, unpublished data). In 2004, an independent panel of internationally recognized experts in public health, infectious diseases, and immunizations reviewed the available data on rubella epidemiology and unanimously agreed that rubella elimination (i.e., the absence of year round endemic transmission) was achieved in the United States.

External link

http://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html

References

Template:WH Template:WS